Final Lists Identifying Manufacturers Subject to Fee Obligations for EPA-Initiated Risk Evaluations Under Section 6 of the Toxic Substances Control Act (TSCA); Notice of Availability, 55283-55286 [2020-19668]
Download as PDF
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
• A conceptual model that describes
the actual or predicted relationships
between the chemical substance, the
conditions of use within the scope of
the evaluation and the receptors, either
human or environmental, with
consideration of the life cycle of the
chemical substance—from
manufacturing, processing, distribution
in commerce, storage, use, and
disposal—and identification of human
and ecological health hazards EPA plans
to evaluate for the exposure scenarios
EPA plans to evaluate.
• An analysis plan, which identifies
the approaches and methods EPA plans
to use to assess exposure, hazards, and
risk, including associated uncertainty
and variability, as well as a strategy for
using reasonably available information
and science approaches.
• A plan for peer review.
Based on public comments received,
the Agency was able to update
conditions of use presented in the draft
scope documents and accept additional
data or information from stakeholders
that was useful to the Agency in
finalizing the scope of the risk
evaluations. In addition, public
comments were considered to better
inform the exposure pathways, routes,
receptors, PESS, and hazards that EPA
plans to consider in the risk evaluations
for the 20 High-Priority Substances.
Note that, as a result of the Ninth Circuit
Court of Appeals’ decision in Safer
Chemicals, Healthy Families v. U.S.
EPA, 943 F.3d 397, 425 (9th Cir. 2019),
EPA will no longer exclude legacy uses
or associated disposal from the
definition of ‘‘conditions of use.’’
Rather, when these activities are
intended, known, or reasonably
foreseen, these activities will be
considered uses and disposal,
respectively, within the definition of
‘‘conditions of use.’’
V. References
The following is a listing of the
documents that are specifically
referenced in this Federal Register
notice. The docket for this action
includes these documents and other
information considered by EPA,
including documents that are referenced
within the documents that are included
in the docket. For assistance in locating
these referenced documents, please
consult the technical person listed
under FOR FURTHER INFORMATION
CONTACT.
1. EPA. High-Priority Substance
Designations Under the Toxic
Substances Control Act (TSCA) and
Initiation of Risk Evaluation on HighPriority Substances; Notice of
Availability. Federal Register. (84 FR
VerDate Sep<11>2014
16:42 Sep 03, 2020
Jkt 250001
71924, December 30, 2019) (FRL–
10003–15).
2. EPA. Draft Scopes of the Risk
Evaluations to Be Conducted for
Thirteen Chemical Substances Under
the Toxic Substances Control Act;
Notice of Availability. Federal Register.
(85 FR 19941, April 9, 2020) (FRL–
10007–11).
3. EPA. Draft Scopes of the Risk
Evaluations to Be Conducted for Seven
Chemical Substances Under the Toxic
Substances Control Act; Notice of
Availability. Federal Register. (85 FR
22733, April 23, 2020) (FRL–10008–05).
4. EPA. Summary of Public Comments
Received on the Draft Scopes of the Risk
Evaluations for Twenty Chemical
Substances Under the Toxic Substances
Control Act (TSCA). (August 2020).
Authority: 15 U.S.C. 2601 et seq.
Andrew Wheeler,
Administrator.
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[ER–FRL–9052–6]
Responsible Agency: Office of Federal
Activities, General Information 202–
564–5632 or https://www.epa.gov/nepa.
Weekly receipt of Environmental Impact
Statements (EIS)
Filed August 24, 2020, 10 a.m. EST
Through August 31, 2020, 10 a.m.
EST
Pursuant to 40 CFR 1506.9.
Notice
Section 309(a) of the Clean Air Act
requires that EPA make public its
comments on EISs issued by other
Federal agencies. EPA’s comment letters
on EISs are available at: https://
cdxnodengn.epa.gov/cdx-enepa-public/
action/eis/search.
EIS No. 20200177, Draft, USFS, AK,
South Revilla Integrated Resource
Project, Comment Period Ends: 10/19/
2020, Contact: Kristin Whisennand
406–626–2505.
EIS No. 20200178, Final, BLM, NV,
Yellow Pine Solar Project, Review
Period Ends: 10/05/2020, Contact:
Whitney Wirthlin 702–515–5284.
EIS No. 20200179, Final, USFS, CA,
Mitsubishi Cement Corporation South
Quarry Plan of Operation, Review
Period Ends: 10/05/2020, Contact:
Scott Eliason 909–382–2830.
Fmt 4703
Dated: August 31, 2020.
Cindy S. Barger,
Director, NEPA Compliance Division, Office
of Federal Activities.
[FR Doc. 2020–19605 Filed 9–3–20; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
Final Lists Identifying Manufacturers
Subject to Fee Obligations for EPAInitiated Risk Evaluations Under
Section 6 of the Toxic Substances
Control Act (TSCA); Notice of
Availability
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
Environmental Impact Statements;
Notice of Availability
Frm 00032
Amended Notice
EIS No. 20200139, Draft, FHWA, MD, I–
495 & I–270 Managed Lanes Study
Draft Environmental Impact
Statement and Draft Section 4(f)
Evaluation, Comment Period Ends:
11/09/2020, Contact: Jeanette Mar
410–779–7152. Revision to FR Notice
Published 7/10/2020; Extending the
Comment Period from 10/8/2020 to
11/9/2020.
[EPA–HQ–OPPT–2019–0677; FRL–10014–
28]
[FR Doc. 2020–19671 Filed 9–3–20; 8:45 am]
PO 00000
55283
Sfmt 4703
As required by the final rule
on fees for the administration of the
Toxic Substances Control Act (TSCA)
(the Fees Rule), in which the
Environmental Protection Agency (EPA)
established fees to defray some of the
costs of administering certain provisions
of TSCA, EPA this document announces
the availability of the final lists
identifying the manufacturers
(including importers) of the 20 chemical
substances that have been designated as
a High-Priority Substance for risk
evaluation and for which fees will be
charged. In January 2020, EPA
announced the availability of and
solicited public comment on the
preliminary lists identifying
manufacturers subject to fee obligations
for EPA-initiated risk evaluations under
TSCA. During the comment period,
which closed on June 15, 2020,
manufacturers (including importers)
were also required to self-identify as a
manufacturer of one of the 20 HighPriority Substances irrespective of
whether they are included on the
preliminary lists. Where appropriate,
entities had the opportunity to avoid or
reduce fee obligations by making certain
certifications consistent with the Fees
Rule. The public had the opportunity to
correct errors or provide comments on
SUMMARY:
E:\FR\FM\04SEN1.SGM
04SEN1
55284
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
the preliminary lists. Manufacturers
(including importers) identified on the
final list will be subject to applicable
fees.
Effective on August 27, 2020.
For
technical information contact: Benjamin
Dyson, Environmental Assistance
Division (7408M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (202) 774–8976;
email address: dyson.benjamin@
epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
DATES:
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action applies to entities that
manufacture (including import) one or
more of the High-Priority Substances
currently undergoing a risk evaluation
under TSCA section 6(b). The action
may also be of interest to chemical
processors, distributors in commerce,
and users; non-governmental
organizations in the environmental and
public health sectors; state and local
government agencies; and members of
the public. The Agency has not
attempted to describe all the specific
entities and corresponding NAICS codes
for entities that may be interested in or
affected by this action.
B. What action is the Agency taking?
EPA is announcing the availability of
the final lists identifying manufacturers
(including importers) that are subject to
fee obligations under 40 CFR 700.45.
These entities manufacture or import
one or more of the 20 High-Priority
Substances subject to EPA-initiated risk
evaluations under TSCA section 6.
jbell on DSKJLSW7X2PROD with NOTICES
C. Why is the Agency taking this action?
As amended by the Frank R.
Lautenberg Chemical Safety for the 21st
Century Act of 2016 (Pub. L. 114–182,
see also https://www.epa.gov/assessingand-managing-chemicals-under-tsca/
frank-r-lautenberg-chemical-safety-21stcentury-act), TSCA authorizes EPA to
establish, by rule, a fee structure to
defray some of the costs of
administering certain provisions of
TSCA. Pursuant to the Fees Rule, the
Agency will collect payment from
identified manufacturers (including
importers) who manufacture (including
VerDate Sep<11>2014
16:42 Sep 03, 2020
Jkt 250001
import) a chemical substance that is the
subject of a risk evaluation under TSCA
section 6(b) (Ref. 1). As intended by
Congress, these fees are a sustainable
source of funds for EPA to fulfill its
legal obligation to conduct risk
evaluations to determine whether a
chemical substance presents an
unreasonable risk of injury to health or
the environment, as required under
TSCA section 6. Pursuant to TSCA
section 6(b) and its implementing
regulations, EPA has designated 20
chemical substances as High-Priority
Substances for risk evaluation (Ref. 2)
(84 FR 71924, December 30, 2019)
(FRL–10003–15); those substances are
listed in Unit III. EPA is now identifying
the manufacturers (including importers)
that are subject to fee obligations
associated with the risk evaluations of
these High-Priority Substances.
D. What is the Agency’s authority for
this action?
TSCA provides EPA with authority to
establish fees to defray a portion of the
costs associated with administering
EPA-initiated TSCA section 6 risk
evaluations. On September 27, 2018,
EPA finalized a rule imposing a fee for
persons who manufacture (including
import) a chemical substance that is the
subject of an EPA-initiated risk
evaluation under TSCA section 6 (Ref.
1). The requirements for those fee
payments are codified in 40 CFR 700.45.
II. Background
A. How was the final list developed?
TSCA section 6(b)(1) requires EPA to
prioritize chemical substances as HighPriority Substances for risk evaluation.
In accordance with TSCA section 6(b)
and 40 CFR 702.7, on March 21, 2019,
EPA initiated the prioritization process
for 20 chemical substances identified as
candidates for High-Priority Substance
designation (Ref. 3). On August 23,
2019, EPA proposed to designate the
same 20 chemical substances as HighPriority Substances for risk evaluation
(Ref. 4). EPA finalized the High-Priority
Substance designations of the same 20
chemical substance proposed for HighPriority Substance designations (Ref. 2)
and announced on January 27, 2020 the
availability of the preliminary lists for
the 20 High-Priority Substances
designated (Ref. 5) (see docket EPA–
HQ–OPPT–2019–0677). EPA provided a
60-day comment period, with two
additional extensions closing the second
comment period on June 15, 2020 (Ref.
6 and Ref. 7) (March 13 (https://
www.regulations.gov/document?D=EPAHQ-OPPT-2019-0677-0058) and May 28
(https://www.regulations.gov/
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
document?D=EPA-HQ-OPPT-20190677-0087).
EPA developed each preliminary list
using the most up-to-date information
available, from information submitted to
the Agency (i.e., information submitted
under TSCA section 8(a) (including the
Chemical Data Reporting (CDR) Rule)
and TSCA section 8(b), and the Toxics
Release Inventory (TRI)). To include the
two most recent CDR reporting cycle
data (collected every four years) and to
account for annual or other typical
fluctuations in manufacturing
(including import), EPA used six years
of data submitted or available to the
Agency under CDR and TRI to create the
preliminary lists (2012–2018). EPA
considered using other sources of
information available to the Agency,
such as publicly available information
(e.g., Panjiva, Datamyne) or information
submitted to other agencies to which
EPA has access (e.g., U.S. Customs and
Border Protection data) but concluded
that data quality limitations would
create more false positives than
appropriate additions to the lists.
Following publication of the
preliminary lists, manufacturers of the
20 High-Priority Substances who had
manufactured or imported the chemical
substance in the previous five years
were required to self-identify to EPA,
irrespective of whether they were
included in the preliminary lists. See 40
CFR 700.45(b)(5).
EPA is now announcing the final list
of manufacturers (including importers)
for the 20 High-Priority Substances who
are responsible for fee payments (Ref. 8).
EPA is also providing the list of
companies that certified to ceasing
manufacture for each of the 20 HighPriority Substances (Ref. 9).
EPA believes the requirement to selfidentify, established by 40 CFR
700.45(b)(5), was sufficient to identify
additional manufacturers (including
importers). Manufacturers (including
importers) on the preliminary lists had
an opportunity to certify through CDX
that: (1) They had already ceased
manufacturing prior to the defined
cutoff dates and will not manufacture
(including import) for five years; or (2)
they have not manufactured the
chemical substance in the five-year
period preceding publication of the
preliminary lists. For this group of 20
chemicals, the cutoff date for ceasing
manufacture or import of a chemical
substance was March 20, 2019, which is
the day prior to initiation of the
prioritization process for the applicable
designated High-Priority Substance. If
EPA received such a certification
statement from a manufacturer, then the
manufacturer was not identified on the
E:\FR\FM\04SEN1.SGM
04SEN1
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
final list and will not be obligated to pay
the fee. Additionally, EPA found that
the broad scope of the current Fees Rule
unintentionally imposes potentially
significant burdens on importers of
chemical substances in articles, and
manufacturers of byproducts and
impurities, and that certain stakeholders
would be obligated to undertake
significant and burdensome efforts to
attempt to determine the presence of the
20 High-Priority Substances in their
products and processes. EPA announced
the Agency’s intention to immediately
begin the rulemaking process to amend
the Fees Rule to propose exemptions to
the self-identification requirements in
the Fees Rule associated with EPAinitiated risk evaluations for three
categories of manufacturers of chemical
substances subject to such risk
evaluations: (1) Importers of articles
containing the chemical substances; (2)
producers of the chemical substances as
a byproduct; and (3) producers or
importers of the chemical substances as
an impurity. As a bridge to the final
revised rule EPA provided a ‘‘No Action
Assurance’’ on March 24, 2020 (Ref. 10).
Additionally, the Agency was asked
whether a manufacturer that has ceased
manufacture of one of the 20 HighPriority Substances prior to the cutoff
date for ceasing manufacture or import
of a chemical substance (March 2019)
other than manufacture in the three
categories impacted by the planned
regulatory change, and that also
commits to not manufacturing the
chemical in the future five years, other
than in those same three categories
should be subject to fee obligations. The
Agency responded that in light of the
rulemaking announcement, EPA does
not expect to identify entities who
otherwise meet the criteria for
‘‘cessation’’ except for manufacture or
potential manufacture in one of the
three categories—and who certify as
such in the ‘‘Additional Information’’
field in CDX—on the final lists of
responsible fee payers. Finally, entities
had the opportunity to certify as to
whether they meet the definition of a
‘‘small business concern’’ as defined in
the Fees Rule and qualify for an 80%
reduced fee amount.
B. What are the final lists and fee
obligations of manufacturers (including
importers)?
This Notice announces the
availability of EPA’s final list of
manufacturers (including importers) of
the 20 High-Priority Substances subject
to risk evaluation who are responsible
for payment of fees, as required by 40
CFR 700.45 (Ref. 2). The final lists are
available at docket number EPA–HQ–
VerDate Sep<11>2014
16:42 Sep 03, 2020
Jkt 250001
OPPT–2019–0677 at https://
www.regulations.govand on EPA’s
website at https://www.epa.gov/TSCAfees. Also included in the docket are the
list of companies that certified to having
ceased manufacturing by March 20,
2019 and have no plans to restart
manufacturing in the next five years
(Ref. 9) as well as those that certified to
not manufacturing the chemical
substance in the five-year period
preceding publication of the
preliminary lists (Ref. 11). The
‘‘Certification of Cessation’’ list also
includes those manufacturers who
ceased manufacturing by March 20,
2019 except for manufacture of a
byproduct, or impurity or in an article.
The final list of manufacturers differs
from the preliminary lists (see docket
number EPA–HQ–OPPT–2019–0677) for
several reasons. For example, many
CDR/TRI manufacturers that were
identified on the preliminary list had
either ceased manufacturing prior to the
cutoff dates were not manufacturers (or
importers) of the chemical substances.
Such entities were not included on the
final lists. Other entities from the
preliminary lists, in accordance with the
planned regulatory change, that only
manufactured (or imported) chemicals
as a byproduct, impurity, or in an article
and certified as such, were not included
in the final list. The only company that
self-identified for TCEP imported a very
small quantity in 2019 for R&D use only.
The Agency used the discretion offered
by the TSCA Fees Rule to not collect a
fee from this one company. As a result,
there are no fees associated with the risk
evaluation for tris (2-chloroethyl)
phosphate (115–96–8). The TSCA Fees
Rule provides EPA flexibility to refine
the final list of manufacturers in a
manner that is reasonable and prudent,
in light of statutory and regulatory
obligations related to TSCA risk
evaluations and associated fee payment
obligations. As such, the Agency
decided to not charge a fee to those
importers who were only importing
small quantities of the 20 HPS for
research and development purposes
only.
This document announces the
availability of EPA’s final list of
manufacturers (including importers) of
the 20 High-Priority Substances subject
to risk evaluation who are responsible
for payment of fees, as required by 40
CFR 700.45 (Ref. 2). The final lists are
available at docket number EPA–HQ–
OPPT–2019–0677 at https://
www.regulations.gov and on EPA’s
website at https://www.epa.gov/TSCAfees. Also included in the docket are the
list of companies that certified to having
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
55285
ceased manufacturing by March 20,
2019 and have no plans to restart
manufacturing in the next five years
(Ref. 9) as well as those that certified to
not manufacturing the chemical
substance in the five-year period
preceding publication of the
preliminary lists (Ref. 11). The
‘‘Certification of Cessation’’ list also
includes those manufacturers who
ceased manufacturing by March 20,
2019 except for manufacture of a
byproduct, or impurity or in an article.
The final list of manufacturers differs
from the preliminary lists (see docket
number EPA–HQ–OPPT–2019–0677) for
several reasons. For example, many
CDR/TRI manufacturers that were
identified on the preliminary list had
either ceased manufacturing prior to the
cutoff dates were not manufacturers (or
importers) of the chemical substances.
Such entities were not included on the
final lists. Other entities from the
preliminary lists, in accordance with the
planned regulatory change, that only
manufactured (or imported) chemicals
as a byproduct, impurity, or in an article
and certified as such, were not included
in the final list. Other entities that were
not included on a preliminary list, such
as importers of chemical substances for
laboratory or R&D use that imported
volumes below the CDR 25,000 lb
threshold, self-identified as a
manufacturer (including importer)
during the reporting period and were
therefore included on a final list. There
are no fees associated with the risk
evaluation for tris (2-chloroethyl)
phosphate (115–96–8).
Fee obligations are set forth in 40 CFR
700.45 and include a total fee of
$1,350,000 for EPA-initiated risk
evaluations, with a reduced fee amount
for small business concerns (Ref. 1). The
total fee is shared amongst all identified
manufacturers (including importers).
The Fees Rule provides more detailed
information on how EPA established the
fee for EPA-initiated risk evaluations
(Ref. 1).
In recognition of the unprecedented
and unforeseen challenges to the
economy as a result of public health
emergency, the Agency is exploring
options for payment flexibilities,
including payment plans and extended
due dates for fees. Manufacturers may
also form a consortium to pay fees in
accordance with 40 CFR 700.45(f)(3).
The consortium must notify EPA that a
consortium has formed within 60 days
of the publication of the final scope of
a risk evaluation. Once established, the
consortium would determine how the
fee would be split among the members,
and ultimately paid to EPA. For
additional information on the possible
E:\FR\FM\04SEN1.SGM
04SEN1
55286
Federal Register / Vol. 85, No. 173 / Friday, September 4, 2020 / Notices
division of costs amongst consortia and
individual manufacturers, please see the
Fees Rule Unit III.J, Multiple Parties
Subject to Fee Obligation (Ref. 1).
C. How can I access the final list?
The final list of manufacturers that
will be subject to the Fees Rule for EPAinitiated risk evaluations under section
6 of TSCA can be found at docket
number EPA–HQ–OPPT–2019–0677 at
https://www.regulations.gov and on
EPA’s website at https://www.epa.gov/
TSCA-fees.
III. Public Comments on Preliminary
Lists and EPA Responses
EPA received public comments from
78 entities on the preliminary lists. As
a general matter, many of the comments
raised questions asking further
clarification of what constitutes a
byproduct or article; requesting a de
minimis exemption; etc. The Agency
responded to the questions by
communicating directly with individual
stakeholders, hosting conference calls
with stakeholders, participating in
webinars for stakeholders, improving
web content, and adding Frequently
Asked Questions to the EPA web page
at https://www.epa.gov/tsca-fees/
frequent-questions-about-tsca-fees-epainitiated-risk-evaluations.
jbell on DSKJLSW7X2PROD with NOTICES
IV. References
The following is a listing of the
documents that are specifically
referenced in this document. The docket
includes these documents and other
information considered by EPA,
including documents that are referenced
within the documents that are included
in the docket, even if the referenced
document is not physically located in
the docket. For assistance in locating
these other documents, please consult
the technical person listed under FOR
FURTHER INFORMATION CONTACT.
1. EPA. Fees for the Administration of the
Toxic Substances Control Act. Federal
Register. (83 FR 52694, October 17, 2018)
(FRL–9984–41).
2. EPA. High-Priority Substance
Designations Under the Toxic Substances
Control Act (TSCA); Notice of Availability.
Federal Register. (84 FR 71924, December 30,
2019) (FRL–10003–15).
3. EPA. Initiation of Prioritization Under
the Toxic Substances Control Act (TSCA);
Notice. Federal Register. (84 FR 10491,
March 21, 2019) (FRL–9991–06).
4. EPA. Proposed High-Priority Substance
Designations Under the Toxic Substances
Control Act (TSCA); Notice of Availability
and Request for Comment. Federal Register.
(84 FR 44300, August 23, 2019) (FRL–9998–
29).
5. EPA. Preliminary Lists Identifying
Manufacturers Subject to Fee Obligations for
EPA-Initiated Risk Evaluations Under
VerDate Sep<11>2014
16:42 Sep 03, 2020
Jkt 250001
Section 6 of the Toxic Substances Control
Act (TSCA): Notice of Availability and
Request for Comment. Federal Register. (85
FR 4661, January 27, 2020) (FRL–10003–14).
6. EPA. Preliminary Lists Identifying
Manufacturers Subject to Fee Obligations for
EPA-Initiated Risk Evaluations Under
Section 6 of the Toxic Substances Control
Act (TSCA): Notice of Availability and
Request for Comment; Extension of Comment
Period. Federal Register. (85 FR 14677,
March 13, 2020) (FRL–10006–03).
7. EPA. Preliminary Lists Identifying
Manufacturers Subject to Fee Obligations for
EPA-Initiated Risk Evaluations Under
Section 6 of the Toxic Substances Control
Act (TSCA): Notice of Availability and
Request for Comment; Extension of Comment
Period. Federal Register. (85 FR 32036, May
28, 2020) (FRL–10010–37).
8. EPA. List of Final Manufacturers for all
20 High Priority Substances. August 2020
9. EPA. List of Manufacturers Who
Certified as Ceasing Manufacture. August
2020.
10. EPA. ‘‘No Action Assurance Letter’’ of
March 24, 2020.
11. EPA. List of Manufactures Who SelfIdentified as ‘‘No Manufacture’’. August
2020.
Office of Land and Emergency
Management, 1200 Pennsylvania Ave.
NW (Mail Code 5104A), Washington,
DC 20460; telephone number: (202)
564–8023; email address: belke.jim@
epa.gov, or: William Noggle, United
States Environmental Protection
Agency, Office of Land and Emergency
Management, 1200 Pennsylvania Ave.
NW (Mail Code 5104A), Washington,
DC 20460; telephone number: (202)
566–1306; email address:
noggle.william@epa.gov.
SUPPLEMENTARY INFORMATION:
AGENCY:
I. How can I get copies of this document
and other related information?
A copy of this Federal Register
notice, the petitions for reconsideration,
and the separate letters describing the
full basis for this action are available in
the rulemaking docket (Docket ID No.
EPA–HQ–OEM–2015–0725). Publicly
available docket materials are available
electronically through
www.regulations.gov. In addition,
following signature, an electronic copy
of this final action and the letters will
be available on the internet at
www.epa.gov/rmp/final-riskmanagement-program-rmpreconsideration-rule. Out of an
abundance of caution for members of
the public and our staff, the EPA Docket
Center and Reading Room are closed to
the public, with limited exceptions, to
reduce the risk of transmitting COVID–
19. Our Docket Center staff will
continue to provide remote customer
service via email, phone, and webform.
We encourage the public to obtain
docket information via https://
www.regulations.gov/. For further
information on EPA Docket Center
services and the current status, please
visit us online at https://www.epa.gov/
dockets.
The U.S. Environmental
Protection Agency (EPA) received three
petitions for reconsideration of the final
revisions to the Accidental Release
Prevention Requirements: Risk
Management Programs under the Clean
Air Act, published in the Federal
Register on December 19, 2019. The
agency is providing notice that it is
denying all three petitions for
reconsideration. The basis for EPA’s
action is set out fully in separate letters
addressed to each petitioner, available
in the rulemaking docket.
DATES: September 4, 2020.
FOR FURTHER INFORMATION CONTACT:
James Belke, United States
Environmental Protection Agency,
II. Judicial Review
Section 307(b)(1) of the CAA indicates
which Federal Courts of Appeal have
venue for petitions of review of final
actions by the EPA. This section
provides, in part, that ‘‘a petition for
review of action of the Administrator in
promulgating . . . any standard of
performance or requirement under
section [111] of [the CAA],’’ or any other
‘‘nationally applicable’’ final action,
‘‘may be filed only in the United States
Court of Appeals for the District of
Columbia.’’
The EPA has determined that its
actions denying the petitions for
reconsideration are nationally
applicable for purposes of CAA section
307(b)(1) because these actions directly
relate to the Risk Management Program
regulations promulgated under CAA
Authority: 15 U.S.C. 2625.
Andrew Wheeler,
Administrator.
[FR Doc. 2020–19668 Filed 9–3–20; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OEM–2015–0725; FRL–10013–31–
OLEM]
Accidental Release Prevention
Requirements: Risk Management
Programs Under the Clean Air Act;
Final Action on Petitions for
Reconsideration
Environmental Protection
Agency (EPA).
ACTION: Notice of final action denying
petitions for reconsideration.
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\04SEN1.SGM
04SEN1
Agencies
[Federal Register Volume 85, Number 173 (Friday, September 4, 2020)]
[Notices]
[Pages 55283-55286]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19668]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2019-0677; FRL-10014-28]
Final Lists Identifying Manufacturers Subject to Fee Obligations
for EPA-Initiated Risk Evaluations Under Section 6 of the Toxic
Substances Control Act (TSCA); Notice of Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As required by the final rule on fees for the administration
of the Toxic Substances Control Act (TSCA) (the Fees Rule), in which
the Environmental Protection Agency (EPA) established fees to defray
some of the costs of administering certain provisions of TSCA, EPA this
document announces the availability of the final lists identifying the
manufacturers (including importers) of the 20 chemical substances that
have been designated as a High-Priority Substance for risk evaluation
and for which fees will be charged. In January 2020, EPA announced the
availability of and solicited public comment on the preliminary lists
identifying manufacturers subject to fee obligations for EPA-initiated
risk evaluations under TSCA. During the comment period, which closed on
June 15, 2020, manufacturers (including importers) were also required
to self-identify as a manufacturer of one of the 20 High-Priority
Substances irrespective of whether they are included on the preliminary
lists. Where appropriate, entities had the opportunity to avoid or
reduce fee obligations by making certain certifications consistent with
the Fees Rule. The public had the opportunity to correct errors or
provide comments on
[[Page 55284]]
the preliminary lists. Manufacturers (including importers) identified
on the final list will be subject to applicable fees.
DATES: Effective on August 27, 2020.
FOR FURTHER INFORMATION CONTACT: For technical information contact:
Benjamin Dyson, Environmental Assistance Division (7408M), Office of
Pollution Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
(202) 774-8976; email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action applies to entities that manufacture (including import)
one or more of the High-Priority Substances currently undergoing a risk
evaluation under TSCA section 6(b). The action may also be of interest
to chemical processors, distributors in commerce, and users; non-
governmental organizations in the environmental and public health
sectors; state and local government agencies; and members of the
public. The Agency has not attempted to describe all the specific
entities and corresponding NAICS codes for entities that may be
interested in or affected by this action.
B. What action is the Agency taking?
EPA is announcing the availability of the final lists identifying
manufacturers (including importers) that are subject to fee obligations
under 40 CFR 700.45. These entities manufacture or import one or more
of the 20 High-Priority Substances subject to EPA-initiated risk
evaluations under TSCA section 6.
C. Why is the Agency taking this action?
As amended by the Frank R. Lautenberg Chemical Safety for the 21st
Century Act of 2016 (Pub. L. 114-182, see also https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/frank-r-lautenberg-chemical-safety-21st-century-act), TSCA authorizes EPA to establish, by
rule, a fee structure to defray some of the costs of administering
certain provisions of TSCA. Pursuant to the Fees Rule, the Agency will
collect payment from identified manufacturers (including importers) who
manufacture (including import) a chemical substance that is the subject
of a risk evaluation under TSCA section 6(b) (Ref. 1). As intended by
Congress, these fees are a sustainable source of funds for EPA to
fulfill its legal obligation to conduct risk evaluations to determine
whether a chemical substance presents an unreasonable risk of injury to
health or the environment, as required under TSCA section 6. Pursuant
to TSCA section 6(b) and its implementing regulations, EPA has
designated 20 chemical substances as High-Priority Substances for risk
evaluation (Ref. 2) (84 FR 71924, December 30, 2019) (FRL-10003-15);
those substances are listed in Unit III. EPA is now identifying the
manufacturers (including importers) that are subject to fee obligations
associated with the risk evaluations of these High-Priority Substances.
D. What is the Agency's authority for this action?
TSCA provides EPA with authority to establish fees to defray a
portion of the costs associated with administering EPA-initiated TSCA
section 6 risk evaluations. On September 27, 2018, EPA finalized a rule
imposing a fee for persons who manufacture (including import) a
chemical substance that is the subject of an EPA-initiated risk
evaluation under TSCA section 6 (Ref. 1). The requirements for those
fee payments are codified in 40 CFR 700.45.
II. Background
A. How was the final list developed?
TSCA section 6(b)(1) requires EPA to prioritize chemical substances
as High-Priority Substances for risk evaluation. In accordance with
TSCA section 6(b) and 40 CFR 702.7, on March 21, 2019, EPA initiated
the prioritization process for 20 chemical substances identified as
candidates for High-Priority Substance designation (Ref. 3). On August
23, 2019, EPA proposed to designate the same 20 chemical substances as
High-Priority Substances for risk evaluation (Ref. 4). EPA finalized
the High-Priority Substance designations of the same 20 chemical
substance proposed for High-Priority Substance designations (Ref. 2)
and announced on January 27, 2020 the availability of the preliminary
lists for the 20 High-Priority Substances designated (Ref. 5) (see
docket EPA-HQ-OPPT-2019-0677). EPA provided a 60-day comment period,
with two additional extensions closing the second comment period on
June 15, 2020 (Ref. 6 and Ref. 7) (March 13 (https://www.regulations.gov/document?D=EPA-HQ-OPPT-2019-0677-0058) and May 28
(https://www.regulations.gov/document?D=EPA-HQ-OPPT-2019-0677-0087).
EPA developed each preliminary list using the most up-to-date
information available, from information submitted to the Agency (i.e.,
information submitted under TSCA section 8(a) (including the Chemical
Data Reporting (CDR) Rule) and TSCA section 8(b), and the Toxics
Release Inventory (TRI)). To include the two most recent CDR reporting
cycle data (collected every four years) and to account for annual or
other typical fluctuations in manufacturing (including import), EPA
used six years of data submitted or available to the Agency under CDR
and TRI to create the preliminary lists (2012-2018). EPA considered
using other sources of information available to the Agency, such as
publicly available information (e.g., Panjiva, Datamyne) or information
submitted to other agencies to which EPA has access (e.g., U.S. Customs
and Border Protection data) but concluded that data quality limitations
would create more false positives than appropriate additions to the
lists. Following publication of the preliminary lists, manufacturers of
the 20 High-Priority Substances who had manufactured or imported the
chemical substance in the previous five years were required to self-
identify to EPA, irrespective of whether they were included in the
preliminary lists. See 40 CFR 700.45(b)(5).
EPA is now announcing the final list of manufacturers (including
importers) for the 20 High-Priority Substances who are responsible for
fee payments (Ref. 8). EPA is also providing the list of companies that
certified to ceasing manufacture for each of the 20 High-Priority
Substances (Ref. 9).
EPA believes the requirement to self-identify, established by 40
CFR 700.45(b)(5), was sufficient to identify additional manufacturers
(including importers). Manufacturers (including importers) on the
preliminary lists had an opportunity to certify through CDX that: (1)
They had already ceased manufacturing prior to the defined cutoff dates
and will not manufacture (including import) for five years; or (2) they
have not manufactured the chemical substance in the five-year period
preceding publication of the preliminary lists. For this group of 20
chemicals, the cutoff date for ceasing manufacture or import of a
chemical substance was March 20, 2019, which is the day prior to
initiation of the prioritization process for the applicable designated
High-Priority Substance. If EPA received such a certification statement
from a manufacturer, then the manufacturer was not identified on the
[[Page 55285]]
final list and will not be obligated to pay the fee. Additionally, EPA
found that the broad scope of the current Fees Rule unintentionally
imposes potentially significant burdens on importers of chemical
substances in articles, and manufacturers of byproducts and impurities,
and that certain stakeholders would be obligated to undertake
significant and burdensome efforts to attempt to determine the presence
of the 20 High-Priority Substances in their products and processes. EPA
announced the Agency's intention to immediately begin the rulemaking
process to amend the Fees Rule to propose exemptions to the self-
identification requirements in the Fees Rule associated with EPA-
initiated risk evaluations for three categories of manufacturers of
chemical substances subject to such risk evaluations: (1) Importers of
articles containing the chemical substances; (2) producers of the
chemical substances as a byproduct; and (3) producers or importers of
the chemical substances as an impurity. As a bridge to the final
revised rule EPA provided a ``No Action Assurance'' on March 24, 2020
(Ref. 10).
Additionally, the Agency was asked whether a manufacturer that has
ceased manufacture of one of the 20 High-Priority Substances prior to
the cutoff date for ceasing manufacture or import of a chemical
substance (March 2019) other than manufacture in the three categories
impacted by the planned regulatory change, and that also commits to not
manufacturing the chemical in the future five years, other than in
those same three categories should be subject to fee obligations. The
Agency responded that in light of the rulemaking announcement, EPA does
not expect to identify entities who otherwise meet the criteria for
``cessation'' except for manufacture or potential manufacture in one of
the three categories--and who certify as such in the ``Additional
Information'' field in CDX--on the final lists of responsible fee
payers. Finally, entities had the opportunity to certify as to whether
they meet the definition of a ``small business concern'' as defined in
the Fees Rule and qualify for an 80% reduced fee amount.
B. What are the final lists and fee obligations of manufacturers
(including importers)?
This Notice announces the availability of EPA's final list of
manufacturers (including importers) of the 20 High-Priority Substances
subject to risk evaluation who are responsible for payment of fees, as
required by 40 CFR 700.45 (Ref. 2). The final lists are available at
docket number EPA-HQ-OPPT-2019-0677 at https://www.regulations.govand on
EPA's website at https://www.epa.gov/TSCA-fees. Also included in the
docket are the list of companies that certified to having ceased
manufacturing by March 20, 2019 and have no plans to restart
manufacturing in the next five years (Ref. 9) as well as those that
certified to not manufacturing the chemical substance in the five-year
period preceding publication of the preliminary lists (Ref. 11). The
``Certification of Cessation'' list also includes those manufacturers
who ceased manufacturing by March 20, 2019 except for manufacture of a
byproduct, or impurity or in an article. The final list of
manufacturers differs from the preliminary lists (see docket number
EPA-HQ-OPPT-2019-0677) for several reasons. For example, many CDR/TRI
manufacturers that were identified on the preliminary list had either
ceased manufacturing prior to the cutoff dates were not manufacturers
(or importers) of the chemical substances. Such entities were not
included on the final lists. Other entities from the preliminary lists,
in accordance with the planned regulatory change, that only
manufactured (or imported) chemicals as a byproduct, impurity, or in an
article and certified as such, were not included in the final list. The
only company that self-identified for TCEP imported a very small
quantity in 2019 for R&D use only. The Agency used the discretion
offered by the TSCA Fees Rule to not collect a fee from this one
company. As a result, there are no fees associated with the risk
evaluation for tris (2-chloroethyl) phosphate (115-96-8). The TSCA Fees
Rule provides EPA flexibility to refine the final list of manufacturers
in a manner that is reasonable and prudent, in light of statutory and
regulatory obligations related to TSCA risk evaluations and associated
fee payment obligations. As such, the Agency decided to not charge a
fee to those importers who were only importing small quantities of the
20 HPS for research and development purposes only.
This document announces the availability of EPA's final list of
manufacturers (including importers) of the 20 High-Priority Substances
subject to risk evaluation who are responsible for payment of fees, as
required by 40 CFR 700.45 (Ref. 2). The final lists are available at
docket number EPA-HQ-OPPT-2019-0677 at https://www.regulations.gov and
on EPA's website at https://www.epa.gov/TSCA-fees. Also included in the
docket are the list of companies that certified to having ceased
manufacturing by March 20, 2019 and have no plans to restart
manufacturing in the next five years (Ref. 9) as well as those that
certified to not manufacturing the chemical substance in the five-year
period preceding publication of the preliminary lists (Ref. 11). The
``Certification of Cessation'' list also includes those manufacturers
who ceased manufacturing by March 20, 2019 except for manufacture of a
byproduct, or impurity or in an article. The final list of
manufacturers differs from the preliminary lists (see docket number
EPA-HQ-OPPT-2019-0677) for several reasons. For example, many CDR/TRI
manufacturers that were identified on the preliminary list had either
ceased manufacturing prior to the cutoff dates were not manufacturers
(or importers) of the chemical substances. Such entities were not
included on the final lists. Other entities from the preliminary lists,
in accordance with the planned regulatory change, that only
manufactured (or imported) chemicals as a byproduct, impurity, or in an
article and certified as such, were not included in the final list.
Other entities that were not included on a preliminary list, such as
importers of chemical substances for laboratory or R&D use that
imported volumes below the CDR 25,000 lb threshold, self-identified as
a manufacturer (including importer) during the reporting period and
were therefore included on a final list. There are no fees associated
with the risk evaluation for tris (2-chloroethyl) phosphate (115-96-8).
Fee obligations are set forth in 40 CFR 700.45 and include a total
fee of $1,350,000 for EPA-initiated risk evaluations, with a reduced
fee amount for small business concerns (Ref. 1). The total fee is
shared amongst all identified manufacturers (including importers). The
Fees Rule provides more detailed information on how EPA established the
fee for EPA-initiated risk evaluations (Ref. 1).
In recognition of the unprecedented and unforeseen challenges to
the economy as a result of public health emergency, the Agency is
exploring options for payment flexibilities, including payment plans
and extended due dates for fees. Manufacturers may also form a
consortium to pay fees in accordance with 40 CFR 700.45(f)(3). The
consortium must notify EPA that a consortium has formed within 60 days
of the publication of the final scope of a risk evaluation. Once
established, the consortium would determine how the fee would be split
among the members, and ultimately paid to EPA. For additional
information on the possible
[[Page 55286]]
division of costs amongst consortia and individual manufacturers,
please see the Fees Rule Unit III.J, Multiple Parties Subject to Fee
Obligation (Ref. 1).
C. How can I access the final list?
The final list of manufacturers that will be subject to the Fees
Rule for EPA-initiated risk evaluations under section 6 of TSCA can be
found at docket number EPA-HQ-OPPT-2019-0677 at https://www.regulations.gov and on EPA's website at https://www.epa.gov/TSCA-fees.
III. Public Comments on Preliminary Lists and EPA Responses
EPA received public comments from 78 entities on the preliminary
lists. As a general matter, many of the comments raised questions
asking further clarification of what constitutes a byproduct or
article; requesting a de minimis exemption; etc. The Agency responded
to the questions by communicating directly with individual
stakeholders, hosting conference calls with stakeholders, participating
in webinars for stakeholders, improving web content, and adding
Frequently Asked Questions to the EPA web page at https://www.epa.gov/tsca-fees/frequent-questions-about-tsca-fees-epa-initiated-risk-evaluations.
IV. References
The following is a listing of the documents that are specifically
referenced in this document. The docket includes these documents and
other information considered by EPA, including documents that are
referenced within the documents that are included in the docket, even
if the referenced document is not physically located in the docket. For
assistance in locating these other documents, please consult the
technical person listed under FOR FURTHER INFORMATION CONTACT.
1. EPA. Fees for the Administration of the Toxic Substances
Control Act. Federal Register. (83 FR 52694, October 17, 2018) (FRL-
9984-41).
2. EPA. High-Priority Substance Designations Under the Toxic
Substances Control Act (TSCA); Notice of Availability. Federal
Register. (84 FR 71924, December 30, 2019) (FRL-10003-15).
3. EPA. Initiation of Prioritization Under the Toxic Substances
Control Act (TSCA); Notice. Federal Register. (84 FR 10491, March
21, 2019) (FRL-9991-06).
4. EPA. Proposed High-Priority Substance Designations Under the
Toxic Substances Control Act (TSCA); Notice of Availability and
Request for Comment. Federal Register. (84 FR 44300, August 23,
2019) (FRL-9998-29).
5. EPA. Preliminary Lists Identifying Manufacturers Subject to
Fee Obligations for EPA-Initiated Risk Evaluations Under Section 6
of the Toxic Substances Control Act (TSCA): Notice of Availability
and Request for Comment. Federal Register. (85 FR 4661, January 27,
2020) (FRL-10003-14).
6. EPA. Preliminary Lists Identifying Manufacturers Subject to
Fee Obligations for EPA-Initiated Risk Evaluations Under Section 6
of the Toxic Substances Control Act (TSCA): Notice of Availability
and Request for Comment; Extension of Comment Period. Federal
Register. (85 FR 14677, March 13, 2020) (FRL-10006-03).
7. EPA. Preliminary Lists Identifying Manufacturers Subject to
Fee Obligations for EPA-Initiated Risk Evaluations Under Section 6
of the Toxic Substances Control Act (TSCA): Notice of Availability
and Request for Comment; Extension of Comment Period. Federal
Register. (85 FR 32036, May 28, 2020) (FRL-10010-37).
8. EPA. List of Final Manufacturers for all 20 High Priority
Substances. August 2020
9. EPA. List of Manufacturers Who Certified as Ceasing
Manufacture. August 2020.
10. EPA. ``No Action Assurance Letter'' of March 24, 2020.
11. EPA. List of Manufactures Who Self-Identified as ``No
Manufacture''. August 2020.
Authority: 15 U.S.C. 2625.
Andrew Wheeler,
Administrator.
[FR Doc. 2020-19668 Filed 9-3-20; 8:45 am]
BILLING CODE 6560-50-P